This topic contains a solution. Click here to go to the answer

Author Question: According to O'Reilly (2005), Web 2.0 Level 1 applications operate offline but gain features from ... (Read 12 times)

tth

  • Hero Member
  • *****
  • Posts: 579
According to O'Reilly (2005), Web 2.0 Level 1 applications operate offline but gain features from going online.
 
  Indicate whether the statement is true or false

Question 2

Despite the failures of individual companies and initiatives, the total volume of EC has been growing each year.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alexisweber49

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

TRUE

Answer to Question 2

TRUE




tth

  • Member
  • Posts: 579
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


peter

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library